Drug intelligence / Profile preview

filtered technetium (99mTc) sulfur colloid

Development stage
Unknown
Lead developer
GE Healthcare
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Nanoparticles → Drug Delivery Systems
Administration
Intradermal, Subcutaneous, Intratumoral
01

Overview

Filtered [99mTc]sulfur colloid (fTcSC) is a diagnostic radiopharmaceutical agent used primarily for sentinel lymph node (SLN) mapping and lymphoscintigraphy in patients with breast cancer or melanoma. It is prepared by passing technetium-99m labeled sulfur colloid through a microfilter (typically 0.1 µm or 0.22 µm) to ensure a smaller, more uniform particle size (usually <100-200 nm). This size reduction facilitates more rapid and efficient migration through lymphatic channels compared to the unfiltered preparation, which contains larger particles that tend to remain at the injection site. Once injected peritumorally or intradermally, the particles are transported to the sentinel lymph node, where they are phagocytosed by macrophages in the reticuloendothelial system, allowing for intraoperative localization using a gamma probe or scintigraphic imaging.

Brand names
AN-Sulfur ColloidTechneScan SULDraxImage Sulfur Colloid
Other names
fTcSCfiltered [99mTc]sulfur colloidfiltered Tc-99m sulfur colloidfiltered technetium Tc 99m sulfur colloidfiltered sulfur colloid

Beyond the preview

Go deeper on filtered technetium (99mTc) sulfur colloid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on filtered technetium (99mTc) sulfur colloid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call